Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a relapsing form of multiple sclerosis, including relapsing-remitting MS or secondary-progressive MS
- People whose level of physical disability falls within a specific range, as measured by a standard MS disability scale called the EDSS (score between 3 and 6.5 — confirm with trial site for what this means for your situation)
- People whose motor (movement-related) function scores fall within a specific range on a standard assessment scale (score between 2 and 4 — confirm with trial site)
- People who have not had a relapse (a flare-up of MS symptoms) for at least one year
- People aged 18 to 75 years old
- People who are safe to have an MRI scan, based on answers to a standard MRI safety questionnaire
- People who are taking the medication dalfampridine, provided the dose has stayed the same for at least two months before the screening visit
Who may not be able to join:
- People whose baseline MRI scan shows active, inflamed MS lesions or signs of a recent stroke-like event in the brain
- People with blood pressure that is outside a controlled range (confirm with trial site for specific values)
- People with a history of epilepsy
- People who have chronic obstructive pulmonary disease (a long-term lung condition)
- People with sleep apnea that is not well controlled
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Milap Sandhu, Pt, PhD, Shirley Ryan AbilityLab
Phone: 3122381435
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ankle Plantarflexion Strength
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.